Medical Product Advertising & Promotion - Webinar Recording/Transcript
Medical Product Advertising & Promotion: Social Media Do's and Don'ts
Social media is a two-edged sword — a boon for getting your message out, a magnet for warning letters should you run afoul of the FDA.
And other agencies are watching your social media behavior too — the FTC and the CPSC, to name two. Time to consult a lawyer? Or simply ...
Two of Washington’s top lawyers specializing in the intersection of social media and federal regulation discuss:
- Common social media mistakes that trigger warning letters
- How to deal with misleading, untruthful and/or biased posts
- FDA enforcement activities to date
- Use of social media for adverse event reporting and product improvement
- Likely FDA moves that could affect your use of social media
- And much more!
Your presenters, Naomi J.L. Halpern Esq. and Georgia C. Ravitz Esq., are experts at the Washington headquarters of Arent Fox LLP. Spend 90 minutes picking their brains — without paying one cent extra in billable hours.
FDA guidances set the social media rules, but also offer useful help — managing your social media presence, for public disclosures for sharing marketing and off-label information, and dealing with damaging information posted on social media.
Social media will only grow more central to your marketing and communications. But it’s a legal minefield too, best navigated with the help of expert lawyers. That’s reason enough to take part in this timely presentation.